Zidovudine

CD1 antigen complex ; Mus musculus







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 20101476 In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue. 2010 Mar 1
2 20155331 In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue. 2010 Jun 1
3 17160102 Toxicology and carcinogenesis studies of transplacental AZT (Cas No. 30516-87-1) in Swiss (CD-1®) mice (in utero studies). 2006 Jun 1
4 14743340 Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage. 2004 1
5 15476197 Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment. 2004 4
6 12543234 Prolonged perinatal AZT administration and early maternal separation: effects on social and emotional behaviour of periadolescent mice. 2003 Feb 1
7 12419493 Developmental exposure to the antiretroviral drug zidovudine increases brain levels of brain-derived neurotrophic factor in mice. 2002 Nov 22 1
8 10091855 Effects of prenatal zidovudine treatment on learning and memory capacities of preweanling and young adult mice. 1999 Feb 3
9 9299194 A transplacental carcinogenicity bioassay in CD-1 mice with zidovudine. 1997 Aug 1